|
- We make healthy possible - Amneal Pharmaceuticals
Amneal Receives U S FDA Approval for Brekiya® (dihydroergotamine mesylate) autoinjector for the Acute Treatment of Migraine and Cluster Headache Episodes See Warning
- Careers - Amneal Pharmaceuticals
We believe when our team members grow, Amneal grows Here you are offered meaningful opportunities to build new skills, explore new experiences and share your ideas
- Our Story - Amneal Pharmaceuticals
More than two decades after our founding, Amneal is better positioned than ever to deliver outcomes that meet important medical needs, make quality medicines more accessible and more affordable, and provide solutions for tomorrow’s health challenges
- Our Portfolio - Amneal Pharmaceuticals
We are also excited about our work to bring patients more affordable biologic therapy options through our Biosciences, which includes a broad portfolio of institutional injectables as well as Amneal’s growing biosimilars portfolio
- Amneal at-a-glance - Amneal Pharmaceuticals
Amneal at-a-glance Our company vitals are strong OUR PORTFOLIO FOCUS Complex Generics Specialty Products
- Amneal Pharmaceuticals, Inc. - Investor Relations
Investor Relations Amneal is a global, diversified biopharmaceutical company that provides access to high-quality, affordable, and essential medicines Press Releases Stock Information 7 92 AMRX (NASDAQ)0 101 22% Pricing delayed 20 minutes 6 23 2025 04:00 PM
- Generic Products - Amneal Pharmaceuticals
View the catalog of Amneal generic products including the epinephrine auto-injector (authorized generic for Adrenaclick)
- Amneal Announces U. S. FDA Approval of Over-the-Counter Naloxone . . .
Amneal’s Naloxone HCI Nasal Spray, manufactured in the U S , is a generic equivalent to OTC NARCAN ® HCI Nasal Spray, a medication that is widely used to help treat drug overdose from opioids, including heroin, fentanyl and prescription opioid medications
|
|
|